Steven J Sperber
Overview
Explore the profile of Steven J Sperber including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
212
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Satlin M, Chen L, Gomez-Simmonds A, Marino J, Weston G, Bhowmick T, et al.
Clin Infect Dis
. 2022 May;
75(12):2066-2075.
PMID: 35522019
Background: Patients with bacteremia due to carbapenem-resistant Enterobacterales (CRE) experience delays until appropriate therapy and high mortality rates. Rapid molecular diagnostics for carbapenemases and new β-lactam/β-lactamase inhibitors may improve outcomes....
2.
Go R, Nyirenda T, Bojarian M, Hosseini D, Kim K, Rahim M, et al.
BMC Infect Dis
. 2022 Mar;
22(1):254.
PMID: 35287602
Background: Racial/ethnic minorities are at higher risk for severe COVID-19. This may be related to social determinants that lead to chronic inflammatory states. The aims of the study were to...
3.
Sivapalasingam S, Lederer D, Bhore R, Hajizadeh N, Criner G, Hosain R, et al.
Clin Infect Dis
. 2022 Feb;
75(1):e380-e388.
PMID: 35219277
Background: Open-label platform trials and a prospective meta-analysis suggest efficacy of anti-interleukin (IL)-6R therapies in hospitalized patients with coronavirus disease 2019 (COVID-19) receiving corticosteroids. This study evaluated the efficacy and...
4.
Go R, Shah R, Nyirenda T, Oe Y, Sarfraz K, Panthappattu J, et al.
Crit Care Explor
. 2021 Jul;
3(7):e0493.
PMID: 34291223
Objectives: To determine methylprednisolone's dose, duration, and administration from onset of symptoms and association with 60 days in hospital survival of coronavirus disease 2019 pneumonia. Design: Cohort study. Setting: Thirteen...
5.
Satlin M, Chen L, Patel G, Gomez-Simmonds A, Weston G, Kim A, et al.
Antimicrob Agents Chemother
. 2017 Feb;
61(4).
PMID: 28167547
Although the New York/New Jersey (NY/NJ) area is an epicenter for carbapenem-resistant (CRE), there are few multicenter studies of CRE from this region. We characterized patients with CRE bacteremia in...
6.
Sperber S, Shah L, Gilbert R, Ritchey T, Monto A
Clin Infect Dis
. 2004 May;
38(10):1367-71.
PMID: 15156472
A randomized, double-blind, placebo-controlled clinical trial was conducted to evaluate the ability of Echinacea purpurea to prevent infection with rhinovirus type 39 (RV-39). Forty-eight previously healthy adults received echinacea or...
7.
Sperber S, Levine J, Gross P
Clin Infect Dis
. 2003 Feb;
36(5):675-6.
PMID: 12594655
No abstract available.